I can't explain other than they either had delays

I can't explain other than they either had delays in getting all the necessary data for Copenhagen or Gerald didn't clearly explain what he was doing. It was my understanding that he was going to wait for the end of the month to release the entire data set. If a misstep in the eyes of investors was had, then so be it. But as I mentioned in my last post, we have NO CLUE as to what happened in Copenhagen as Gerald and his team met with important individuals and companies to explain Lympro. Many hare having a knee jerk reaction, mostly from the fact that the stock dropped after the Monday eruption. Would we be having any of this conversation had the stock not acted at all or had the pps not sank? I don't know but we certainly will know the guts of Lympro by the end of the month. And from there we'll know if this company has any balls or has been stuffing ping pong balls in its shorts. For the sake of Gerald's credibility, the life of his company and our investment in AMBS, I truly hope this company has some nice big balls to show off soon.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.